Select Page

Light for Sight foundation


Keratoconus is the leading cause of severe visual impairment in children and adolescents worldwide. The disease often remains undetected for a long time and can lead to blindness at a later stage. Children and adolescents are at the greatest risk, as the disease is the most aggressive in these age groups.

The Light for Sight foundation now unites more than 25 countries in the fight against keratoconus.


The goal of LightforSight is to eliminate preventable blindness in children and adolescents with keratoconus.

This goal should be achieved as follows:

  • Sensitize those affected and their families for the disease keratoconus
  • Sensitize healthcare professionals on the link between keratoconus and adolescent age
  • Establish screening actions and competence centres
  • Financial support to cover the treatment costs, if necessary
  • Supporting research projects related to keratoconus.

LightforSight 21

Children and adolescents with Down syndrome (trisomy 21) are at a high risk of developing keratoconus

Before the advent of cross-linking technology, the only treatment option was corneal transplantation. However, this is a particular risk especially in people with Down’s syndrome, as many sufferers very often rub their eyes, which can lead to a bleeding of the sutures of the graft and a loss of the cornea and the eye

The best way to treat this condition in people with Down syndrome is early detection. The aim of the initiative is to provide all ophthalmologists with cross-linking information about the disease and the treatment options, as well as to encourage parents to have their children, especially children with Down syndrome, undergo an examination. Last but not least, all other medical professionals involved in the care of people with Down Syndrome, such as general practitioners and paediatricians, must also be informed.

Postmenopausal therapy – a new risk factor for keratoconus progression?

Many women with endometriosis receive “selective tissue estrogenic ...
Read more

ELZA at FHNW Olten

ELZA at FHNW Olten
On March 10, 2020, ELZA’s medical director, Prof ...
Read more

Children: to cross-link or not to cross-link?

Children: to cross-link or not to cross-link? If a ...
Read more

ELZA at SAMIR 2018 in Tanger

SAMIR 2018
The ELZA Institute was represented at the 2018 ...
Read more

How long does the effect of cross-linking last?

How long does cross-linking last? See this video ...
Read more

Switzerland’s first Down Syndrome eye consultation

November 10, 2017: Keratoconus affects about 1 in ...
Read more

2nd edition of the textbook “Corneal Cross-Linking” available at ASCRS 2017

Our Textbook on Corneal Cross-Linking available at ASCRS ...
Read more

Expat Expo 2017: ELZA supports Light for Sight’s screening for keratoconus

March 2017. ELZA will support Light for Sight's screening for ...
Read more

June 2016: Cross-Linking in Down Syndrome

Cross-Linking in Down Syndrome: Interview with Nikki Hafezi ...
Read more

Cross-linking in children: the “Light for Sight”-Foundation

Schweizer Illustrierte. Keratoconus treatment by cross-linking in children ...
Read more

The ELZA Institute

DE |